An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
Palestinians in Gaza have been celebrating the news of a ceasefire and hostage release deal reached between Israel and Hamas.…
MILANO (ITALPRESS) – Perde due punti per strada l’Inter di Simone Inzaghi, che nel primo dei due match da recuperare…
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
Today, we look at the news that a deal has been reached to stop the fighting in Gaza and for…
ROMA (ITALPRESS) – Nel corso del Tg1 delle 20 il direttore artistico del Festival di Sanremo Carlo Conti ha svelato…